Abstract:Acute myeloid leukemia (AML) is a stem cell-driven malignancy of the blood forming (hematopoietic) system. Despite of high dose chemotherapy with toxic side effects, many patients eventually relapse. The "7+3 regimen", which consists of 7 days of cytarabine in combination with daunorubicin during the first 3 days, is a widely used therapy protocol. Since peripheral blood cells are easily accessible to longitudinal sampling, significant research efforts have been undertaken to characterize and reduce adverse effects on circulating blood cells. However, much less is known about the impact of the 7+3 regimen on human hematopoietic stem cells and their physiological micro-environments, the so-called stem cell niches. One reason for this is the technical inability to observe human stem cells in vivo and the discomfort related to bone marrow biopsies. To better understand the treatment effects on human stem cells, we consider a mechanistic mathematical model of the stem cell niche before, during and after chemotherapy. The model accounts for different maturation stages of leukemic and hematopoietic cells and considers key processes such as cell proliferation, self-renewal, differentiation and therapy-induced cell death. In the model, hematopoietic (HSCs) and leukemic stem cells (LSCs) compete for a joint niche and respond to both systemic and niche-derived signals. We relate the model to clinical trial data from literature which longitudinally quantifies the counts of hematopoietic stem like (CD34+CD38-ALDH+) cells at diagnosis and after therapy. The proposed model can capture the clinically observed interindividual heterogeneity and reproduce the non-monotonous dynamics of the hematopoietic stem like cells observed in relapsing patients. Our model allows to simulate different scenarios proposed in literature such as therapy-related impairment of the stem cell niche or niche-mediated resistance. Model simulations suggest that during the post-therapy phase a more than 10-fold increase of hematopoietic stem-like cell proliferation rates is required to recapitulate the measured cell dynamics in patients achieving complete remission. We fit the model to data of 7 individual patients and simulate variations of the treatment protocol. These simulations are in line with the clinical finding that G-CSF priming can improve the treatment outcome. Furthermore, our model suggests that a decline of HSC counts during remission might serve as an indication for salvage therapy in patients lacking MRD (minimal residual disease) markers.

Analysis of the Lymphocytopoiesis Dynamics in Nonirradiated and Irradiated Humans: A Modeling Approach

A Biomathematical Model of Lymphopoiesis and Its Application to Acute and Chronic Irradiation Assessment

A Mathematical Model of Myelodysplastic Syndromes: the Effect of Stem Cell Niches

A BIOMATHEMATICAL MODEL OF LYMPHOPOIESIS FOLLOWING SEVERE RADIATION ACCIDENTS—POTENTIAL USE FOR DOSE ASSESSMENT

Modeling the Depressed Hematopoietic Cells for Immune System under Chronic Radiation

Dependence of the human leukemia risk on the dose and dose rate of continuous irradiation: Modeling study

Mathematical model for assessment of radiation risk on long space missions

Effects of Partial-Body, Continuous/Pulse Irradiation at Dose Rates from Flash to Conventional Rates on the Level of Surviving Blood Lymphocytes: Modeling Approach. I. Continuous Irradiation

CHARACTERIZATION OF THE RADIATION-DAMAGED PRECURSOR CELLS IN BONE MARROW BASED ON MODELING OF THE PERIPHERAL BLOOD GRANULOCYTES RESPONSE

A Cell Kinetic Model of Granulopoiesis under Radiation Exposure: Extension from Rodents to Canines and Humans.

A stochastic model of blood flow to calculate blood dose during radiotherapy

Effects of Partial-Body, Continuous/Pulse Irradiation at Dose Rates from Flash to Conventional Rates on The Level of Surviving Blood Lymphocytes: Modeling Approach II. Two- and Multiple-Pulse Irradiation

Model of age-dependent dynamics and biokinetics of T-cells as natural biodosimeters

Impact of radiation therapy on healthy and cancerous cell dynamics: a Mathematical analysis

Linking Doses with Clinical Scores of Hematopoietic Acute Radiation Syndrome

Modelling post-chemotherapy stem cell dynamics in the bone marrow niche of AML patients

Digitalization of A Non-Irradiated Acute Myeloid Leukemia Model

Mathematical modeling and dynamic analysis of anti-tumor immune response

Elucidating the Effects of Ionizing Radiation on Immune Cell Populations: A Mathematical Modeling Approach with Special Emphasis on Fractional Derivatives

A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies

Stochastic biophysical modeling of irradiated cells